Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenoptin in Hyperphenylalaninemia Due to Primary BH4 Deficiency
NCT00355264Phase 2Completed
- Sponsor
- BioMarin Pharmaceutical
- Start
- Aug 2006
- Primary completion
- Jun 2009
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 2 trial of sapropterin in tetrahydrobiopterin deficiency (BH4D), sponsored by BioMarin Pharmaceutical. Started Aug 2006; status: completed.
02
Drugs
sapropterin
03
Conditions
tetrahydrobiopterin deficiency (BH4D)
Beyond the preview
Go deeper on NCT00355264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00355264.